Jungmin Lee

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer”.

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer

Cancer Treatment Reviews(2020)10.1016/j.ctrv.2020.102021

N/A

0DataRank · unranked

169 citations

Erika J. Lampert, Cynthia Coots, Jungmin Lee, Tzu‐Ting Huang

Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-1439

N/A

0DataRank · unranked

38 citations

Ethan Brill, Jayakumar R. Nair, Xiaohu Zhang, Kelli M. Wilson, Lu Chen +3 more

Anaplastic features (AnaF) and DNA-damage repair pathway (DDR) mutations in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.92

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Marijo Bilušić, Lisa M. Cordes, Jennifer L. Marté, Helen Owens +6 more

The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2

Science(2022)10.1126/science.abp8337

N/A

0DataRank · unranked

251 citations

Andrew F. Magee, Edyth Parker, Niema Moshiri, Katherine Izhikevich, Jennifer L. Havens +24 more

Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer

iScience(2024)10.1016/j.isci.2024.111283

N/A

0DataRank · unranked

7 citations

Tzu‐Ting Huang, Anu D. Sunkara, Margaret R. Pruitt, Kristen R. Ibanez, Chih-Yuan Chiang +6 more